Fig. 1From: Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularityStudy design. Overall schematic of multicenter enrollment as well as standardized cardiovascular magnetic resonance (CMR) acquisition and analysis. Note that both enrolling sites employed a tailored CMR protocol for assessment of CMET, inclusive dedicated long inversion time (TI) late gadolinium enhancement (LGE)-CMR for evaluation of contrast-enhancement pattern within lesions. Ancillary clinical data were collected in a uniform manner, including baseline cancer-related indices, embolic events, and mortality following CMRBack to article page